Bayzed Health Group (HKSE:02609) Notes Receivable: HK$0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02609 Bayzed Health Group Inc HKSE:02609
12 GF Score
Price HK$2.99
! 2 Warning Signs
View Full Analysis

What is Bayzed Health Group Notes Receivable?

Bayzed Health Group HKSE:02609 -1.81% 12 Notes Receivable is HK$0 Mil as of Dec. 2025. GuruFocus rates HKSE:02609 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Bayzed Health Group's Notes Receivable for the quarter that ended in Dec. 2025 was HK$0 Mil.

Bayzed Health Group Notes Receivable Related Terms

Bayzed Health Group Notes Receivable Historical Data

* Premium members only.

The historical data trend for Bayzed Health Group's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayzed Health Group Notes Receivable Chart

Bayzed Health Group Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Bayzed Health Group Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
HKSE:02609
12GF Score
Bayzed Health Group Inc HKSE:02609
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayzed Health Group Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of HK$0 Mil mean?
Bayzed Health Group (HKSE:02609) has a Notes Receivable of HK$0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Bayzed Health Group and its competitors.
Is Bayzed Health Group's Notes Receivable too high?
Bayzed Health Group's current Notes Receivable is HK$0 Mil. Overall, Bayzed Health Group has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bayzed Health Group's Notes Receivable compare to HCA and THC?
Bayzed Health Group's Notes Receivable of HK$0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Bayzed Health Group and its competitors. Bayzed Health Group's current Notes Receivable is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayzed Health Group stock overvalued right now?
Bayzed Health Group (HKSE:02609) has a current Notes Receivable of HK$0 Mil. The current Notes Receivable is HK$0 Mil. Bayzed Health Group's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Bayzed Health Group (HKSE:02609), the current Notes Receivable is HK$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bayzed Health Group Business Description

Address No. 16 Lize Road, Room 2401, Mingfeng Tower Office Building, Fengtai District, Beijing, CHN
Bayzed Health Group Inc is an oncology healthcare group that principally engages in the investment in, and provision of, medical and healthcare related services in the PRC. It operates and manages a network of eight hospitals in Beijing, Tianjin, Shanxi Province, Anhui Province, and Henan Province, with a strategic focus on the provision of full-cycle oncology healthcare services through its direct ownership of the equity interest in six private for-profit hospitals and management over two private not-for-profit hospitals.
12GF Score

Get the complete analysis for HKSE:02609

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.99
Price